Experiment 505996

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

LUPEOL

Details

PropertyValue
Pharmacology
ANTIUROLITHIASIS ACTIVITY
Administration routeINTRAGASTRIC
OrganismEmpty organism
CitationANAND,R: PATNAIK,GK: KULSHRESHTHA,DK: DHAWAN,BN:. (1994). ANTIUROLITHIATIC ACTIVITY OF LUPEOL, THE ACTIVE CONSTITUENT ISOLATED FROM CRATEVA NURVALA.. 8(7)
Amount utilized
Compound isolated
DiseaseCMPD DOSED DAILY X16 WEEKS, PREVENTED DEVEOPMENT OF STONES ON IMPLATED NIDUS, CAUSED DISSOLUTION OF PREFORMED STONES AND INCREASED URINARY CREATININE, CALCIUM, PHOSPHATE AND OXALATE.
Dose amount10.0 MG
Number1
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE